Skip to main content
. 2017 Nov 13;7:15445. doi: 10.1038/s41598-017-15827-2

Table 1.

Baseline characteristics according to the presence of microalbuminuria.

Microalbuminuria (+) (n = 365) Microalbuminuria (−) (n = 3020) P value
Age (years) 55 ± 9 52 ± 9 <0.001
Male gender 125 (34.2) 1378 (45.6) <0.001
Hypertension 72 (19.7) 351 (11.6) <0.001
Current smoking status 61 (16.7) 675 (22.4) 0.069
CAD 1 (0.3) 20 (0.7) 0.559
PAD 0 12 (0.4) 0.402
Stroke 5 (1.4) 33 (1.1) 0.746
SBP, mmHg 136 ± 23 123 ± 19 <0.001
DBP, mmHg 87 ± 13 80 ± 12 <0.001
Heart rate 66 ± 8 64 ± 8 <0.001
Metabolic syndrome 102 (27.9) 817 (27.1) 0.709
Triglyceride ≥ 150 mg/dl 186 (51.0) 1216 (40.3) <0.001
Low HDL 214 (58.6) 1696 (56.2) 0.372
Abdominal obesity 101 (27.7) 911 (30.2) 0.334
Hypertension 60 (16.4) 492 (16.3) 0.940
Impaired fasting glucose 70 (19.2) 341 (11.3) <0.001
Creatinine, mg/dl 0.8 ± 0.3 0.8 ± 0.1 0.189
HbA1C, % 5.64 ± 0.4 5.59 ± 0.3 0.007
Prediabetes 181 (49.6) 1252 (41.5) 0.004
BMI, kg/m2 24.9 ± 3.3 24.4 ± 3.1 0.003
Current alcohol 146 (40) 1345 (44.5) 0.408
Regular activity 216 (59.2) 1816 (60.1) 0.735
Family history of diabetes 37 (10.1) 294 (9.7) 0.780
Follow up duration (years) 8.3 ± 2.8 8.5 ± 2.6 0.108

Values are presented as mean ± standard deviation or n (%).

BMI, body mass index; CAD, coronary artery disease; DBP, diastolic blood pressure; HDL, high-density lipoprotein; HbA1c, haemoglobin A1c; PAD, peripheral artery disease; SBP, systolic blood pressure.

HHS Vulnerability Disclosure